CNBX News and Press, Cannabics Pharmaceuticals Inc

CNBX Pharmaceuticals Inc (CNBX) is expected to report for Q1 2003

CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma PR Newswire REHOVOT, Israel and BETHESDA, MD , Nov. 8, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader i...

CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy PR Newswire REHOVOT, Israel and BETHESDA, MD. , Oct. 18, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of...

CNBX Pharmaceuticals ( OTCQB:CNBX ) said on Thursday it had filed a patent application titled composition and method for treating cancer with cannabinoids with the US Patent and Trademark Office and Israel Patent Office. The company said the patent...

CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel PR Newswire REHOVOT, Israel and BETHESDA, Md. , Oct. 13, 2022 /PRNewswire/ - CNBX Pharmaceuticals Inc. (OTC-QB: CNBX),&#...

CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate PR Newswire REHOVOT, Israel and BETHESDA, Md. , Sept. 29, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the ...

CNBX Pharmaceuticals Announces New Patent Granted in Australia PR Newswire REHOVOT, Israel and BETHESDA, MD . , Sept. 28, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabino...

Cannabics Pharmaceuticals  (OTCQB:CNBX +6.3%) said on Thursday it had received a grant of patent notice by the Hong Kong Patent Registry for System and Method for High Throughput Screening of Cancer Cells. The Hong Kong Patent Registry validates the approach to drug discovery i...

CNBX Pharmaceuticals Granted Patent in Hong Kong PR Newswire TEL AVIV, Israel and BETHESDA, Md. , May 5, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based med...

Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals PR Newswire TEL AVIV, Israel and BETHESDA, Md. , March 28, 2022 /PRNewswire/ --  Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer relate...